USSC launches Ray spinal fusion implant following FDA approval Oct. 29.
This article was originally published in The Gray Sheet
Executive Summary
USSC RAY SPINAL FUSION CAGE AVAILABLE IMMEDIATELY following FDA approval Oct. 29 of a premarket approval application for the device. The approval covers use of the device in a range of sizes (12 mm, 14 mm, 16 mm and 18 mm diameters and 21 and 26 mm lengths) for treatment of symptomatic degenerative disk disease (DDD) of the lumbar spine via a posterior surgical approach.
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.